Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

Guangzhou Pharma May Form China Generics JV with Teva Pharma

publication date: Nov 3, 2017

Guangzhou Pharma may partner with Teva Pharma, the world's largest generic drugmaker, to form a JV that would bring the Israeli company's generics to China, according to a Bloomberg article. Teva refused to confirm the JV plans, but it didn't deny them either. The two companies already have a relationship: Guangzhou Pharma is awaiting China approval of several Teva generics. Teva does not currently have a major China presence, a surprise given the company's size and generic drug offerings. More details....

Stock Symbol: (NYSE: TEVA)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.